SynCath NeuroScience
Cerebral Assist Device for Neurointensive Care
Company Overview
Snapshot
Founded in August 2018 by Ofer Barnea and Omer Doron, SynCath NeuroScience operated with 1–10 employees. The company raised $920K across two funding rounds. In January 2019, SynCath NeuroScience received a grant from the Israel Innovation Authority.
Business overview
SynCath NeuroScience is a preclinical-stage medical technology startup focused on developing ECG-synchronized dynamic ICP-modulation technology. The company's core product is a disposable, autonomous ICP-modulation probe designed to enhance cerebral blood flow through synchronized deflate-inflate actions within each cardiac cycle. This in-dwelling probe is delivered via an external ventricular drain (EVD)-like catheter, initially targeting patients instrumented with an EVD. SynCath NeuroScience operates within the Health Tech & Life Sciences sector, specifically in Medical Devices, Diagnostics Devices, and Medical Treatment & Therapeutics, serving the healthcare provider market.
Strategic signal
In December 2023, SynCath NeuroScience ceased operations, indicating a significant shift in its trajectory. This event signals to investors and innovation teams that the company's preclinical development of its cerebral assist device has concluded, marking the end of its journey in the neurointensive care market.
Company Intelligence Q&A
- What is SynCath NeuroScience's primary focus?
- SynCath NeuroScience is a preclinical-stage medical technology startup developing ECG-synchronized dynamic ICP-modulation technology for neurointensive care.
- When was SynCath NeuroScience founded and by whom?
- SynCath NeuroScience was founded in August 2018 by Ofer Barnea and Omer Doron.
- What was a significant operational update for SynCath NeuroScience?
- SynCath NeuroScience ceased to operate in December 2023.
- What type of funding did SynCath NeuroScience receive in January 2019?
- In January 2019, SynCath NeuroScience secured a grant from the Israel Innovation Authority.
- What is the total capital raised by SynCath NeuroScience?
- SynCath NeuroScience raised a total of $920K across two funding rounds.